Abstract
The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Current Pharmaceutical Analysis
Title: Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization
Volume: 5 Issue: 2
Author(s): Luc J. Nagels, Bert Vissers, Hugo Bohets, Joseph Everaert and Johan Robbens
Affiliation:
Abstract: The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Export Options
About this article
Cite this article as:
Nagels J. Luc, Vissers Bert, Bohets Hugo, Everaert Joseph and Robbens Johan, Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172898
DOI https://dx.doi.org/10.2174/157341209788172898 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences
Cardiovascular & Hematological Agents in Medicinal Chemistry A Clinical Perspective: Anti Taus Treatment in Alzheimers Disease
Current Alzheimer Research Inflammation and Innate Immune Response Against Viral Infections in Marine Fish
Current Pharmaceutical Design Toll-Like Receptor System in the Human Endometrium
Current Immunology Reviews (Discontinued) Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
Current Neuropharmacology Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Inflammation & Allergy - Drug Targets (Discontinued) RNAi for the Treatment of Prion Disease: A Window for Intervention in Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Beyond Cholinesterase Inhibition: Anti-Inflammatory Role and Pharmacological Profile of Current Drug Therapy for Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Expression and Function of Cytokines and Chemokines in Neuropsychiatric Related Systemic Lupus Erythematosus
Current Rheumatology Reviews Proteases in Mosquito Borne Diseases: New Avenues in Drug Development
Current Topics in Medicinal Chemistry Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Current Medicinal Chemistry Interactions of Pyrimidine Derivatives with Dihydrofolate Reductase and Thymidylate Synthase: Directions Toward Combating toxoplasmosis
Current Bioactive Compounds Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches
Infectious Disorders - Drug Targets Identification of Pyrazole Derivative as an Antiviral Agent Against Chikungunya Through HTVS
Letters in Drug Design & Discovery NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites
Current Topics in Medicinal Chemistry Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS
Current Drug Metabolism A Review of Current and Prospective Treatments for Channelopathies, with a Focus on Gene and Protein Therapy
Current Pharmaceutical Design